Lingjiao Meng
Papers
2
Total Citations
21
H-Index
2
About
Lingjiao Meng is a surgical oncologist whose research focuses on the intersection of body composition and outcomes in robotic gastric cancer surgery. Her work has pioneered the investigation of sarcopenia and myosteatosis—conditions of low muscle mass and fatty muscle infiltration—as critical predictors of postoperative complications and long-term survival. In her landmark 2024 study, which has already garnered 16 citations, Meng demonstrated through propensity score matching that preoperative sarcopenia significantly increases complication rates and worsens prognosis in patients undergoing robotic gastrectomy. She further extended this line of inquiry with a second highly-cited 2024 paper showing that myosteatosis independently predicts adverse outcomes, even after adjusting for confounders. By providing surgeons with novel, quantifiable risk stratification tools, Meng’s research enables more personalized perioperative care and better-informed consent for gastric cancer patients. Her work is particularly impactful given the rising adoption of robotic surgery and the persistent challenge of high morbidity in gastrectomy. Through rigorous propensity score analyses, Meng has established body composition metrics as actionable biomarkers, advancing both clinical practice and the evidence base for minimally invasive gastric cancer treatment.
Research Focus
Key Achievements
Top Papers
- 1
- 2